Drug profile · INN
modafinil
APO-MODAFINIL
modafinil (APO-MODAFINIL) is a dopamine transporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — modafinil
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 8
- Programs
- 31
- Data quality
- 0.89
Quick answer
modafinil (APO-MODAFINIL) is a dopamine transporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine transporter inhibitor
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 9382200
Process for the preparation of and crystalline forms of optical enantiomers of modafinil
granted -
US 8975442
Process for the preparation of and crystalline forms of optical enantiomers of modafinil
granted -
US 8729305
Process for the preparation of and crystalline forms of optical enantiomers of modafinil
granted -
US 8563014
Modafinil oral lyophilizate
granted -
US 8048222
Highly pure modafinil
granted -
US 7960586
Purification of armodafinil
granted -
US 7235691
Crystalline forms of modafinil
granted -
US 6849120
Oxidation method for preparing highly pure modafinil, crystalline forms of modafinil, and methods of preparing the crystalline forms
expired
Frequently asked questions
What is modafinil?
modafinil (APO-MODAFINIL) is a dopamine transporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for modafinil?
APO-MODAFINIL is a marketed brand name for modafinil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of modafinil?
modafinil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.